Robert Sutton, MD, will fulfill leadership role within the Department of Anesthesiology and Critical Care Medicine.

CHOP neurosurgeons collaborated with researchers from the University of Pennsylvania School of Medicine to confirm the presence of these neurons from birth through age 92.

Researchers found daycare attendance was associated with increased emergency department visits, steroid use, and chronic respiratory symptoms in preterm children with chronic lung disease.

CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.

In April, the Office of Community Impact officially welcomed John William Chin as the new CHOP Cares Community Advisory Board Chair. He has served on CHOP Cares Community Advisory Board for the past three years. 

Children living in the neighborhoods around the Children’s Hospital of Philadelphia campus in West and Southwest Philadelphia have experienced more than their fair share of trauma, which only increased with the COVID-19 pandemic and the rise in gun violence. 

Much progress has been made over the last 25 years when it comes to identifying the genetic mutation that is causing a child’s congenital hyperinsulinism (HI). 

If Leela Morrow, PsyD, the psychologist for the Congenital Hyperinsulinism Center at Children’s Hospital of Philadelphia, gives your child a referral for a neuropsychology evaluation it’s nothing to be afraid of. In fact, it may give your child a roadmap to success.

Many children with hyperinsulinism (HI) have feeding aversion — as many as 60%. The use of tube feedings, and possibly continuous dextrose, to control their blood sugar, among other things (effect of medications, the appetite suppressing effects of insulin, etc.), may exacerbate their aversion to eating by mouth. 

Funding aims to reduce health disparities for patient and families living in West Philadelphia, extending CHOP’s overall community impact.